login
login

Europe Daily Bulletin No. 12805

6 October 2021
EU RESPONSE TO COVID-19 / Health
EMA could give opinion on approval of Covid-19 treatment candidate Regkironawithin two months

05/10/2021 (Agence Europe)On Monday 4 October, the European Medicines Agency began the evaluation of a market authorisation application for the monoclonal antibody Regkirona (CT-P59), which could be used to treat adults with Covid-19 who do not require additional oxygen therapy but are at increased risk of progression to severe Covid-19. The application was submitted by Celltrion Healthcare Hungary Kft and, according to the EMA, could be answered within two months, “depending on the...

Contents

EXTERNAL ACTION
ECONOMY - FINANCE - BUSINESS
EU RESPONSE TO COVID-19
SECTORAL POLICIES
EUROPEAN PARLIAMENT PLENARY
FUNDAMENTAL RIGHTS - SOCIETAL ISSUES
COUNCIL OF EUROPE
NEWS BRIEFS